Cardinal Health (CAH)
Distributes pharmaceuticals and manufactures medical products for healthcare providers.
Something off on this page? Send us feedback.
Distributes branded, generic, and specialty medicines to U.S. pharmacies and healthcare providers, while manufacturing and distributing medical products globally. Most revenue comes from pharmaceutical distribution, supplemented by specialty-practice services, home medical supplies, radiopharmaceuticals, and healthcare logistics.
Distributes branded, generic, over-the-counter, and specialty pharmaceuticals to pharmacies, hospitals, and other U.S. healthcare providers. Pharmaceutical and Specialty Solutions supplies most revenue and combines high-volume distribution with manufacturer services, data analytics, and management support for specialty physician practices; the Red Oak Sourcing venture with CVS Health negotiates generic drug contracts.
Manufactures Cardinal Health-branded medical, surgical, and laboratory products and distributes both proprietary and national brands across the United States, Canada, and other international markets. at-Home Solutions serves patients and home-care providers, Nuclear and Precision Health Solutions prepares radiopharmaceuticals, and OptiFreight Logistics manages healthcare shipping.
Earnings depend on large customer and supplier relationships, manufacturer-set drug prices, regulated distribution and manufacturing, and multiyear opioid-settlement payments.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 19, 2026 | RBC Capital | Initiate | Rating: —Target: — | Target: $276 |
| Aug 13, 2026 | Barclays | Reiterate | Rating: —Target: $258 | Target: $275 |
| Aug 12, 2026 | Morgan Stanley | Reiterate | Rating: —Target: $255 | Target: $265 |
| Aug 12, 2026 | Evercore ISI | Reiterate | Rating: —Target: $240 | Target: $270 |
| Aug 12, 2026 | UBS | Reiterate | Rating: —Target: $274 | Target: $280 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $4.86B · Total debt $9.95B · Total assets $57.30B · Shareholders' equity −$2.88B
- Revenue
- $63.86B
- Operating income
- $729.0M
- Net income
- $394.0M
HistoryDividendAnnual yieldUpcoming
| Institutions | 89.62% | 208.43M shares | |
|---|---|---|---|
| 1,547 holders · as of Jun 30, 2026 | |||
| Insiders | 0.25% | 578.1K shares | |
| 20 holders · as of Aug 20, 2026 | |||
| Other | 10.13% | 23.56M shares | |
| remainder | |||
232.58M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 11.39% | 26.49M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.58% | 15.29M | as of Jun 30, 2026 |
Wellington Management Group LLPInstitution | 6.39% | 14.86M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 5.90% | 13.72M | as of Jun 30, 2026 |
State Street CorpInstitution | 5.15% | 11.97M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 19, 2026 | Mary C. Scherer | officer: Chief Accounting Officer | −2,302 | $237.39 |
| Aug 19, 2026 | Jason M. Hollar | officer: Chief Executive Officer | −44,529 | $236.18 |
| Aug 18, 2026 | Jason M. Hollar | officer: Chief Executive Officer | −80,000 | $235.74 |
| Aug 18, 2026 | Michelle D. Greene | officer: Chief Information Officer | −11,650 | $235.72 |
| Aug 18, 2026 | Jessica L. Mayer | officer: Chief Legal/Compliance Officer | −29,436 | $236.19 |
